CLIN.L Share Price (CLIN)

Let us be honest, it has been a bad roller coaster like alot of AIM stocks for the last 5 years. For years it underperformed and made a couple of very poor acquisitions. Best be it gone.

The vote was passed.
It is now over to the regulators, but as there is no real change to the business (it is being bought by a fund rather than a competitor) this should be a formality hence they expect to complete the deal in Q2.
The sp now reflects an nterest rate until the deal is done. They probably need US, UK and EU competition authorities to approve the deal.

please can you explain if the votes were fully met and the final outcome as I I don't understand about certain pending conditions

Yes all will feel they have gained from the transaction and there is enough room for improvement for triton to justify not overpaying.

How long before there is a trade merger and then a relisting at a higher value?

Fair result all around I’d say.